Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · USD
$11.5
+0.28 (+2.5%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first RNA analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 196M | |
|---|---|---|
| Revenue (ttm) | 36.7M | |
| Net income (ttm) | -58.7M | |
| EPS (ttm) | -$3.43 | |
| Shares out | 17.1M | |
| Volume | 91,830 | |
| Beta | 0.93 | |
| Price target | $25.0 | +118.2% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 36.7M
- Net income (ttm)
- -58.7M
- EPS (ttm)
- -$3.43
- Market cap
- 196M
Fair-value bridge
- Current price
- $11.5
Analyst consensus
Recommendation
Strong Buy
Price target
$25.0
+118.2%
In the news
Latest news · RNA
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 196M
- P/S
- 5.3x
- P/B
- 0.8x
Profitability
- Gross margin
- -32.9%
- Operating margin
- -162.1%
Balance sheet
- Debt / equity
- 0.01
- Current ratio
- 13.04
- Quick ratio
- 12.91
Trading
- Beta
- 0.93
- Volume
- 91,830
- Dividend yield
- 0.0%